GSK analyst price targets, scored
Every published price target on GSK in the AnaChart record, 2012-08-13 to 2026-01-06, with whether the stock reached it and how many calendar days that took.
Price targets
109
2012-08-13 to 2026-01-06
Scored
109
target and price both known
Reached
29
26.6% of scored, no time limit
Median days to hit
336
mean 493
Analysts
47
one identity per person
Ask for the GSK file or a question about it, first one free The $29 file covers S&P 500 and Nasdaq-100 names; other tickers are quoted to the job.
Analysts covering GSK, by scored targets
| Analyst | Scored | Reached | Share | Mean days | Last action |
|---|---|---|---|---|---|
| James Gordon | 15 | 2 | 13.3% | 184 | 2026-01-06 |
| Laura Sutcliffe | 14 | 2 | 14.3% | 788 | 2022-07-20 |
| Emmanuel Papadakis | 8 | 0 | 0.0% | 2025-02-06 | |
| Mark Purcell | 7 | 1 | 14.3% | 105 | 2024-07-22 |
| Luisa Hector | 6 | 0 | 0.0% | 2023-02-10 | |
| Emily Field | 6 | 0 | 0.0% | 2024-11-08 | |
| Peter Welford | 5 | 5 | 100.0% | 296 | 2024-11-12 |
| Justin Smith | 4 | 4 | 100.0% | 390 | 2022-05-17 |
| Andrew Baum | 4 | 1 | 25.0% | 67 | 2024-02-13 |
| Graham Parry | 3 | 1 | 33.3% | 50 | 2022-12-05 |
| Richard Vosser | 3 | 0 | 0.0% | 2023-02-02 | |
| Andrew Jeffrey | 3 | 2 | 66.7% | 320 | 2020-05-13 |
| Eric LE Berrigaud | 3 | 0 | 0.0% | 2024-11-01 | |
| James Faucette | 2 | 1 | 50.0% | 1521 | 2018-11-08 |
| Arren Cyganovich | 2 | 0 | 0.0% | 2021-07-29 | |
| Steve Scala | 2 | 2 | 100.0% | 256 | 2019-09-03 |
| Kerry Holford | 2 | 1 | 50.0% | 179 | 2024-12-02 |
| Faham Baig | 1 | 0 | 0.0% | 2020-10-05 | |
| Graham Perry | 1 | 1 | 100.0% | 1 | 2022-12-05 |
| Dominic Lunn | 1 | 0 | 0.0% | 2021-10-26 | |
| Ashwin Shirvaikar | 1 | 0 | 0.0% | 2019-08-07 | |
| Elmar Kraus | 1 | 0 | 0.0% | 2022-02-11 | |
| Geoffrey Porges | 1 | 0 | 0.0% | 2021-03-23 | |
| Vincent Caintic | 1 | 0 | 0.0% | 2021-08-02 | |
| John Eade | 1 | 1 | 100.0% | 442 | 2024-07-16 |
| John Boris | 1 | 1 | 100.0% | 0 | 2018-12-13 |
| Jeffrey Holford | 1 | 1 | 100.0% | 2240 | 2016-07-14 |
| Keyur Parekh | 1 | 0 | 0.0% | 2023-02-24 | |
| James Schneider | 1 | 0 | 0.0% | 2018-11-07 | |
| Jason Kupferberg | 1 | 1 | 100.0% | 1536 | 2018-06-18 |
| Jeff Cantwell | 1 | 1 | 100.0% | 1515 | 2019-05-08 |
| Rajan Sharma | 1 | 1 | 100.0% | 518 | 2025-06-30 |
| Tien-tsin Huang | 1 | 0 | 0.0% | 2019-05-08 | |
| Peter Christiansen | 1 | 0 | 0.0% | 2020-05-13 | |
| Mark Palmer | 1 | 0 | 0.0% | 2018-11-06 | |
| Matt Howlett | 1 | 0 | 0.0% | 2020-11-06 | |
| Trung Huynh | 1 | 0 | 0.0% | 2021-04-15 | |
| Alistair Campbell | 0 | 0 | 2020-11-02 | ||
| JO Walton | 0 | 0 | 2024-07-08 | ||
| Mark Clark | 0 | 0 | 2013-05-28 | ||
| John Davis | 0 | 0 | 2019-08-08 | ||
| Michael Leuchten | 0 | 0 | 2025-10-27 | ||
| Richard Parkes | 0 | 0 | 2020-02-10 | ||
| Richard Purkiss | 0 | 0 | 2016-09-23 | ||
| Seamus Fernandez | 0 | 0 | 2024-10-31 | ||
| Steve Mcgarry | 0 | 0 | 2022-02-18 | ||
| Vincent Meunier | 0 | 0 | 2018-03-22 |
How the scoring works
Direction is the target against the raw close on the day it was published. A target is reached when the stock trades through it in that direction on any later day, with no time limit, tested against the raw daily high or low. Days to hit are calendar days to the first such day. Targets are kept as printed and split-adjusted, with the ratio beside them. Rows are never restated.
Ask for the GSK file or a question about it, first one free The $29 file covers S&P 500 and Nasdaq-100 names; other tickers are quoted to the job.